Baby Formula Shortage Across the U.S. Not a Reflection of Global Supply Chain Disruption
Supply Chain Matters highlights the ongoing and concerning shortage of infant baby formula across the U.S. and provides clarity that this situation does not stem from a global supply chain disruption
by Bob Ferrari 
TraceLink Makes Multiple Product Platform Announcements
In this special edition of Supply Chain Matters This Week in Supply Chain Technology, we highlight announcements made by B2B Industry Specific Network provider TraceLink.
by Bob Ferrari 
Oracle’s Latest Announcement of Cloud Based SCM Applied to Healthcare Industry Supplier Management Challenges
Supply Chain Matters highlights another announcement by Oracle regarding newly announced Cloud based supply chain management technology, now applied to needs for healthcare businesses in supplier rebate management.
by Bob Ferrari 
FDA Announces Winners of Low-Cost Food Traceability Challenge
The Supply Chain Matters blog highlights and comments on the FDA’s New Era of Smarter Food Safety Low or No Cost Traceability Challenge, demonstrating cost effective means to support end-to-end supply chain item level traceability.
by Bob Ferrari 
United States to Invest $2.7 Billion in Domestic Vaccine Supply Chain
The Supply Chain Matters blog highlights the Biden Administration plans to invest $2.7 billion into domestic supply network capabilities of essential vaccine components
by Bob Ferrari
When it Comes to Vaccines- Supply Chain Resiliency Has Active Support
The Supply Chain Matters blog highlights how current and future COVID-19 vaccine supply has drawn active supply chain resiliency actions. In an example is Moderna’s announced deal with Canada to build and operate a domestic MRNA vaccine production facility in that country.
by Bob Ferrari 
Fixing the U.S. Medical PPE Supply Network
This Supply Chain Matters editorial commentary provides highlights of added developments specifically related to U.S. supplies of medical PPE and how government and private industry actions still appear not to be aligned.
by Bob Ferrari 
Looking Back and Current Viewpoint of U.S. Domestic Production of Medical PPE
The Supply Chain Matters blog provides a look back and current viewpoint of efforts to encourage a U.S. domestic production capability of medical PPE. Based on one domestic supplier’s perspective, optimism still prevails especially around more educated and more risk aware healthcare procurement teams
by Bob Ferrari 
Supply Chain Matters Global Supply Chain News Capsule Follow-Up- June 12 2021
The Supply Chain Matters blog provides an updated capsule of noteworthy updates to prior global supply chain news developments that we have previously highlighted for our readers. In this update, we update developments related to the distribution of the Johnson and Johnson COVID-19 vaccine, and in Airbus efforts to renew monthly manufacturing volumes.
by Bob Ferrari
Supply Chain Matters Global Supply News Capsule Follow-Up
The Supply Chain Matters blog provides a capsule of noteworthy updates to prior global supply chain news developments. Included companies and developments in this update are Johnson and Johnson, Canadian National and Kansas City Southern Railroad, railroad, Blue Yonder and Kinaxis, and the initial legal trade disputes related to the USMCA trade agreement.
by Bob Ferrari
Global COVID-19 Vaccine Production and Distribution Setbacks More Visible
In this Supply Chain Matters COVID-19 Healthcare Delivery Supply Chain News Capsule we highlight the latest developments related to global availability of COVID-19 vaccine supply, along with the reported existence of counterfeit vaccine supplies.
by Bob Ferrari
The Johnson & Johnson Vaccine Production Mix-up- The Message of Stepped-Up Quality Monitoring and Controls
The Supply Chain Matters blog provides commentary on last week’s revelation of a COVID-19 vaccine production facility’s snafu in producing the Johnson & Johnson vaccine. The commentary addresses what mitigation actions the industry needs to undertake to insure the quality needs of COVID-19 vaccines produced at such volumes.
by Bob Ferrari 
SUSTAINING SPONSORS
